INS and diabetes mellitus: First, for generalizability to real-world practice, we identified a real-world representative cohort of T2D patients who were GLP-1RA and insulin users in the analyses and implemented a rigorous matching algorithm to match on a range of baseline patient characteristics (demographics, comorbidities, diabetes severity, concurrent medications) to achieve a greater level of between-group comparability.